Hanwha Chemical To Sell Pharmaceutical Division

News: Hanwha Chemical, a subsidiary of South Korea's Hanwha Group, will sell its fully owned pharmaceutical division Dream Pharma in an effort to boost its finances and focus on its core portfolio of chemical materials and solar power. Hanwha Chemical has chosen Citigroup Global Markets Korea Securities to manage the sale. Hanwha is pushing ahead with plans to sell its stake in the unit, but this is still at an an early stage, according to an unnamed official close to the matter.

This article is tagged to:
Related sectors of this article: Pharmaceuticals & Healthcare
Geography: South Korea

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.